A

Aquestive Therapeutics

AQST

3.60000
USD
-0.23
(-6.01%)
مغلق
حجم التداول
15,779
الربح لكل سهم
0
العائد الربحي
0
P/E
-14
حجم السوق
464,404,776
أصول ذات صلة
A
ADMP
0
(0%)
0.000000 USD
A
AXSM
-1.255
(-1.44%)
86.075 USD
E
EGRX
-0.04000
(-0.83%)
4.78000 USD
JNJ
2.930
(1.86%)
160.770 USD
MRK
0.680
(0.60%)
113.800 USD
NVS
0.650
(0.58%)
112.100 USD
PFE
0.115
(0.38%)
30.650 USD
PG
4.847
(3.01%)
165.620 USD
T
TEVA
0.100
(0.57%)
17.530 USD
VRTX
9.75
(1.97%)
505.40 USD
الأخبار المقالات

العنوان: Aquestive Therapeutics

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.